Global Immunohematology Market by End Use (Hospitals, Blood banks, Diagnostic Laboratories), by Product (Immunohematology Reagent, Immunohematology Analyzer) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
In 2015, the global immunohematology market was worth USD 1.5 billion. This market will see significant growth due to the introduction of new technologies and product launches. The growth is being accelerated by hospitals and diagnostic laboratories shifting to automated instrumentation and integration across multiple functions on a single platform.
U.S. Immunohematology Market by Product, 2013-2024 (USD Million).
Industry players are investing more in research and development to boost market growth. Grifols spent USD 256.97million and USD 211.95million in R&D during 2015 and 2014.
In the industry, there is a growing emphasis on diversification. As an expansion strategy, mergers and acquisitions are a dynamic strategy that key industry players employ.
Immucor purchased Sirona Genomics for USD 14.4 Million in March 2016. The original deal was signed in 2014, and it was completed in 2016. The company plans to include HLA typing products into its product portfolio. This deal was originally signed in 2014 and completed in 2016.
Product Insights
2015 saw the largest market share for immunohematology reagents. Due to the growing demand for immunohematology reagents and an increase in blood banks, this segment accounted a large share of 2015's market. Automated analyzers work with a specific set of reagents. This makes them a mandatory and recurring purchase in hospitals and diagnostic labs.
Automated immunohematology analyzers are expected to grow faster over the forecast period. Automated analyzers can be more precise and provide quicker results. They also consume less reagents. Some analyzers can display digital results immediately on the screen. This allows for faster screening and categorization.
End-Use Information
The largest market share for immunohematology was held by hospitals. Hospitals must check blood donated for infection, determine the parameters for hematology components and conduct pre-transfusion compatibility testing of recipients and donors.
Market for immunohematology, by end-use in 2015
Transfusions are made more efficient and safer by using cell counters, analyzers and reagents. Due to an increase in blood banks, increased awareness about donation and an increase in voluntary donors around the world, blood banks make up the majority of shareholders. Grifols has more than 43 plasma collection centres in the United States as part of their vertical integration strategy. They acquired Grifols in 2002.
Regional Insights
North America was the biggest market in 2015 High demand for immunohematology products is due to the high number of blood banks and trauma centers in this region.
A large number of target diseases such as cancer and sickle cell disease are contributing to the high demand. Multiple blood transfusions are required for patients with sickle cell disease and those suffering from cancer. Sickle cell disease affects approximately 0.1 million people. Additionally, 1,000 babies are born each year with the condition.
Its large share is also due to the acceptance of new technology and preference for automated technology. Companies are eager to launch products in the region because the U.S. FDA has granted clearance for many advanced technology-based products.
Europe is expected to be a key shareholder in the hematology industry. This region is helped by the presence of industry giants like Grifols, Roche Diagnostics Corporation and Siemens Healthcare. Asia Pacific is projected to experience growth during the forecast period. The untapped potential in the region is being highlighted by industry players who are expanding their presence.
Siemens' new Shenzhen healthcare image center was opened in July 2015. It houses a diagnostic imaging unit, conducts workshops, presents, and meets with immunohematology technologists. Roche Diagnostics Corporation also invested USD 455 millions in 2014 to expand its Chinese diagnostic business.
Market Share in Immunohematology
Bio-Rad Laboratories, Inc., Immucor, Ortho Clinical Diagnostics, Grifols, BD (Becton Dixonson); Hologic, Inc., Siemens Healthcare GmbH, ThermoFisher, Abbott, and Beckman Coulter, Inc. are some key industry players.
Market consolidation is being helped by the dynamic merger and acquisition activity in the sector. Many companies have adopted the strategy of acquiring smaller players to increase their product offerings as a key strategy for growth.
Immucor, for example, acquired the transplant and other immune-monitoring sections of Hologic, Inc. in March 2013. It was expected that it would complement the product portfolio. It was originally owned by Gen-Probe Incorporated, which Hologic, Inc. purchased in August 2012.
Major companies are constantly introducing new products to increase market growth. Ortho Vision is a transfusion analyzer that was launched by Ortho Clinical Diagnostics in August 2015. It is currently available in the U.S.
Immunohematology Market Report Scope
The Report Covers Certain Segments
This report provides a forecast of revenue growth as well as an analysis of the most recent trends in each sub-segment from 2013 to 2024. Grand View Research has divided the global immunohematology market by product, region, and end-use.
- Product Outlook (Revenue USD Million; 2013-2024)
-
Analyzer for immunohematology
-
Reagent for immunohematology
-
- End-Use Outlook: Revenue, USD Million; 2013-2024
-
Hospitals
-
Blood banks
-
Diagnostic laboratories
-
- Regional Outlook (Revenue USD Million; 2013-2024)
-
North America
-
The U.S.
-
Canada
-
-
Europe
-
U.K.
-
Germany
-
-
Asia Pacific
-
Japan
-
China
-
India
-
-
Latin America
-
Brazil
-
Mexico
-
-
MEA
-
South Africa
-
-
These are the most frequently asked questions about this report
What is the size of the immunohematology marketb. Global immunohematology market was valued at USD 1.85 Billion in 2019, and will reach USD 1.94 Billion by 2020.
What is the growth rate of the immunohematology market?b. Global immunohematology markets are expected to grow at a compound annual rate of 5.0% between 2016 and 2024, reaching USD 2.36 billion in 2024.
Which market segment had the largest share of immunohematology?b. With a 42.0% share in 2019, North America was the leader of the immunohematology market. This is due to the large number of trauma centers, blood bank facilities, and large cohort of target diseases such as cancer.
What are the major players in the immunohematology marketb. b.
What are the driving factors for the immunohematology marketb. Market growth is driven by the development of new technologies for blood screening, and product launches. Key players are investing more in research and development.
Up Market Research published a new report titled “Immunohematology Market research report which is segmented by End Use (Hospitals, Blood banks, Diagnostic Laboratories), by Product (Immunohematology Reagent, Immunohematology Analyzer), By Players/Companies Bio-Rad Laboratories, Inc, Inc; Siemens Healthineers; ThermoFisher; Abbott; and Beckman Coulter, Inc; Immucor; Ortho Clinical Diagnostics; Grifols; BD (Becton Dickinson); Hologic”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
| Report Attributes | Report Details |
| Report Title | Immunohematology Market Research Report |
| By End Use | Hospitals, Blood banks, Diagnostic Laboratories |
| By Product | Immunohematology Reagent, Immunohematology Analyzer |
| By Companies | Bio-Rad Laboratories, Inc, Inc; Siemens Healthineers; ThermoFisher; Abbott; and Beckman Coulter, Inc; Immucor; Ortho Clinical Diagnostics; Grifols; BD (Becton Dickinson); Hologic |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 200 |
| Number of Tables & Figures | 140 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Immunohematology Market Report Segments:
The market is segmented by End Use (Hospitals, Blood banks, Diagnostic Laboratories), by Product (Immunohematology Reagent, Immunohematology Analyzer).
Immunohematology Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Immunohematology Market
Overview of the regional outlook of the Immunohematology Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Immunohematology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Immunohematology Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Hospitals
2. Blood banks
3. Diagnostic Laboratories
7. By Product:1. Immunohematology Reagent
2. Immunohematology Analyzer
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunohematology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Immunohematology Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunohematology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immunohematology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immunohematology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immunohematology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immunohematology Market Size & Forecast, 2018-2028
4.5.1 Immunohematology Market Size and Y-o-Y Growth
4.5.2 Immunohematology Market Absolute $ Opportunity
Chapter 5 Global Immunohematology Market Analysis and Forecast by End Use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End Use
5.1.2 Basis Point Share (BPS) Analysis by End Use
5.1.3 Absolute $ Opportunity Assessment by End Use
5.2 Immunohematology Market Size Forecast by End Use
5.2.1 Hospitals
5.2.2 Blood banks
5.2.3 Diagnostic Laboratories
5.3 Market Attractiveness Analysis by End Use
Chapter 6 Global Immunohematology Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Immunohematology Market Size Forecast by Product
6.2.1 Immunohematology Reagent
6.2.2 Immunohematology Analyzer
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Immunohematology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immunohematology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Immunohematology Analysis and Forecast
9.1 Introduction
9.2 North America Immunohematology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Immunohematology Market Size Forecast by End Use
9.6.1 Hospitals
9.6.2 Blood banks
9.6.3 Diagnostic Laboratories
9.7 Basis Point Share (BPS) Analysis by End Use
9.8 Absolute $ Opportunity Assessment by End Use
9.9 Market Attractiveness Analysis by End Use
9.10 North America Immunohematology Market Size Forecast by Product
9.10.1 Immunohematology Reagent
9.10.2 Immunohematology Analyzer
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Immunohematology Analysis and Forecast
10.1 Introduction
10.2 Europe Immunohematology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Immunohematology Market Size Forecast by End Use
10.6.1 Hospitals
10.6.2 Blood banks
10.6.3 Diagnostic Laboratories
10.7 Basis Point Share (BPS) Analysis by End Use
10.8 Absolute $ Opportunity Assessment by End Use
10.9 Market Attractiveness Analysis by End Use
10.10 Europe Immunohematology Market Size Forecast by Product
10.10.1 Immunohematology Reagent
10.10.2 Immunohematology Analyzer
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Immunohematology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Immunohematology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Immunohematology Market Size Forecast by End Use
11.6.1 Hospitals
11.6.2 Blood banks
11.6.3 Diagnostic Laboratories
11.7 Basis Point Share (BPS) Analysis by End Use
11.8 Absolute $ Opportunity Assessment by End Use
11.9 Market Attractiveness Analysis by End Use
11.10 Asia Pacific Immunohematology Market Size Forecast by Product
11.10.1 Immunohematology Reagent
11.10.2 Immunohematology Analyzer
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Immunohematology Analysis and Forecast
12.1 Introduction
12.2 Latin America Immunohematology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Immunohematology Market Size Forecast by End Use
12.6.1 Hospitals
12.6.2 Blood banks
12.6.3 Diagnostic Laboratories
12.7 Basis Point Share (BPS) Analysis by End Use
12.8 Absolute $ Opportunity Assessment by End Use
12.9 Market Attractiveness Analysis by End Use
12.10 Latin America Immunohematology Market Size Forecast by Product
12.10.1 Immunohematology Reagent
12.10.2 Immunohematology Analyzer
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Immunohematology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Immunohematology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Immunohematology Market Size Forecast by End Use
13.6.1 Hospitals
13.6.2 Blood banks
13.6.3 Diagnostic Laboratories
13.7 Basis Point Share (BPS) Analysis by End Use
13.8 Absolute $ Opportunity Assessment by End Use
13.9 Market Attractiveness Analysis by End Use
13.10 Middle East & Africa (MEA) Immunohematology Market Size Forecast by Product
13.10.1 Immunohematology Reagent
13.10.2 Immunohematology Analyzer
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Immunohematology Market: Competitive Dashboard
14.2 Global Immunohematology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad Laboratories
14.3.2 Inc
14.3.3 Inc; Siemens Healthineers; ThermoFisher; Abbott; and Beckman Coulter
14.3.4 Inc; Immucor; Ortho Clinical Diagnostics; Grifols; BD (Becton Dickinson); Hologic
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunohematology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immunohematology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immunohematology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immunohematology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immunohematology Market Size & Forecast, 2018-2028
4.5.1 Immunohematology Market Size and Y-o-Y Growth
4.5.2 Immunohematology Market Absolute $ Opportunity
Chapter 5 Global Immunohematology Market Analysis and Forecast by End Use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End Use
5.1.2 Basis Point Share (BPS) Analysis by End Use
5.1.3 Absolute $ Opportunity Assessment by End Use
5.2 Immunohematology Market Size Forecast by End Use
5.2.1 Hospitals
5.2.2 Blood banks
5.2.3 Diagnostic Laboratories
5.3 Market Attractiveness Analysis by End Use
Chapter 6 Global Immunohematology Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Immunohematology Market Size Forecast by Product
6.2.1 Immunohematology Reagent
6.2.2 Immunohematology Analyzer
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Immunohematology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immunohematology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Immunohematology Analysis and Forecast
9.1 Introduction
9.2 North America Immunohematology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Immunohematology Market Size Forecast by End Use
9.6.1 Hospitals
9.6.2 Blood banks
9.6.3 Diagnostic Laboratories
9.7 Basis Point Share (BPS) Analysis by End Use
9.8 Absolute $ Opportunity Assessment by End Use
9.9 Market Attractiveness Analysis by End Use
9.10 North America Immunohematology Market Size Forecast by Product
9.10.1 Immunohematology Reagent
9.10.2 Immunohematology Analyzer
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Immunohematology Analysis and Forecast
10.1 Introduction
10.2 Europe Immunohematology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Immunohematology Market Size Forecast by End Use
10.6.1 Hospitals
10.6.2 Blood banks
10.6.3 Diagnostic Laboratories
10.7 Basis Point Share (BPS) Analysis by End Use
10.8 Absolute $ Opportunity Assessment by End Use
10.9 Market Attractiveness Analysis by End Use
10.10 Europe Immunohematology Market Size Forecast by Product
10.10.1 Immunohematology Reagent
10.10.2 Immunohematology Analyzer
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Immunohematology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Immunohematology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Immunohematology Market Size Forecast by End Use
11.6.1 Hospitals
11.6.2 Blood banks
11.6.3 Diagnostic Laboratories
11.7 Basis Point Share (BPS) Analysis by End Use
11.8 Absolute $ Opportunity Assessment by End Use
11.9 Market Attractiveness Analysis by End Use
11.10 Asia Pacific Immunohematology Market Size Forecast by Product
11.10.1 Immunohematology Reagent
11.10.2 Immunohematology Analyzer
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Immunohematology Analysis and Forecast
12.1 Introduction
12.2 Latin America Immunohematology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Immunohematology Market Size Forecast by End Use
12.6.1 Hospitals
12.6.2 Blood banks
12.6.3 Diagnostic Laboratories
12.7 Basis Point Share (BPS) Analysis by End Use
12.8 Absolute $ Opportunity Assessment by End Use
12.9 Market Attractiveness Analysis by End Use
12.10 Latin America Immunohematology Market Size Forecast by Product
12.10.1 Immunohematology Reagent
12.10.2 Immunohematology Analyzer
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Immunohematology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Immunohematology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Immunohematology Market Size Forecast by End Use
13.6.1 Hospitals
13.6.2 Blood banks
13.6.3 Diagnostic Laboratories
13.7 Basis Point Share (BPS) Analysis by End Use
13.8 Absolute $ Opportunity Assessment by End Use
13.9 Market Attractiveness Analysis by End Use
13.10 Middle East & Africa (MEA) Immunohematology Market Size Forecast by Product
13.10.1 Immunohematology Reagent
13.10.2 Immunohematology Analyzer
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Immunohematology Market: Competitive Dashboard
14.2 Global Immunohematology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad Laboratories
14.3.2 Inc
14.3.3 Inc; Siemens Healthineers; ThermoFisher; Abbott; and Beckman Coulter
14.3.4 Inc; Immucor; Ortho Clinical Diagnostics; Grifols; BD (Becton Dickinson); Hologic
Segments Covered in the Report
The global Immunohematology market has been segmented based on
By End Use
The global Immunohematology market has been segmented based on
By End Use
- Hospitals
- Blood banks
- Diagnostic Laboratories
- Immunohematology Reagent
- Immunohematology Analyzer
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Bio-Rad Laboratories
- Inc
- Inc; Siemens Healthineers; ThermoFisher; Abbott; and Beckman Coulter
- Inc; Immucor; Ortho Clinical Diagnostics; Grifols; BD (Becton Dickinson); Hologic
Our Clients
Related Reports
Some other reports from this category!
